ABVC BioPharma, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate
ABVC BioPharma, Inc. (ECOC) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate of 83.86% for the 12-month period ending 2023-12-31, per its 10-Q filed 2024-08-14.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate · last filed 2024-11-14
- ABVC BioPharma, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2021 was 108.51%, a 21.91% increase from fiscal 2020.
- ABVC BioPharma, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2020 was 89.01%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 12 month |
|---|---|
| 2023-12-31 | 83.86% 10-Q · filed 2024-08-14 |
| 2022-12-31 | 83.86% 10-Q · filed 2024-11-14 |
| 2021-12-31 | 108.51% 10-K · filed 2023-03-31 |
| 2020-12-31 | 89.01% 10-K · filed 2022-03-31 |
| 2019-12-31 | 89.01% 10-Q · filed 2021-05-10 |
| 2011-12-31 | 260.00% 10-Q/A · filed 2012-08-20 |